Format

Send to

Choose Destination
Lancet Respir Med. 2018 Apr;6(4):237-238. doi: 10.1016/S2213-2600(18)30080-8.

B cells or T cells in TB: a continuing conundrum.

Author information

1
Champalimaud Foundation, Immunotherapy, Lisbon, Portugal; Krankenhaus Nordwest, Frankfurt, Germany. Electronic address: markus.maeurer@fundacaochampalimaud.pt.
2
Champalimaud Foundation, Immunotherapy, Lisbon, Portugal.
3
Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
PMID:
29595500
DOI:
10.1016/S2213-2600(18)30080-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center